Porton Fine Chem buys fellow China intermediates firm Dongbang
Porton Fine Chemicals will buy fellow China-based firm Jiangxi Dongbang Pharmaceutical adding intermediates for antivirals and cholesterol busters to its portfolio.
Archives for March 16, 2015
US DEA drug ingredient quota review failings increasing shortages says GAO
The DEA's mismanagement of the controlled substance API quota system and its poor relationship with the FDA have exacerbated drug shortages according to the US GAO.
Endotoxin and microbial testing to become portable
Bacterial testing is moving from the lab to the manufacturing floor, says an expert at CRO Charles River.